Table 3 Subgroup analyses of the effect size of AIP on baPWV

Age (year)

 < 60

1315

0.73 (0.23, 1.22)

 ≥ 60

3429

1.02 (0.50 1.55)

Sex (n %)

 Male

2366

1.64 (1.12, 2.17)

 Female

2378

0.89 (0.35, 1.44)

BMI (kg/m²)

 < 24

2831

1.72 (1.17, 2.28)

 ≥ 24

1911

0.89 (0.39, 1.39)

SBP

 < 140

1650

1.46 (0.90, 2.02)

 ≥ 140, < 160

2032

1.49 (0.89, 2.08)

 ≥ 160

1062

1.57 (0.54, 2.61)

DBP

 < 90

2491

1.48 (0.96, 2.01)

 ≥ 90, < 100

1562

1.44 (0.78, 2.11)

 ≥ 100

691

1.78 (0.61, 2.96)

eGFR (ml/min/1.73 m²)

 < 60

505

2.37 (0.91, 3.83)

 ≥ 60

4239

1.29 (0.90, 1.67)

HCY (μmol/L)

 ≤ 15

2303

1.16 (0.65, 1.67)

 > 15

2441

1.51 (0.95, 2.07)

Self-reported diabetes (n %)

 No

3920

1.30 (0.88, 1.72)

 Yes

824

1.53 (0.63, 2.43)

Coronary artery disease (n %)

 No

4452

1.31 (0.92, 1.69)

 Yes

292

1.99 (0.41, 3.57)

Stroke (n %)

 No

4439

1.32 (0.96, 1.74)

 Yes

305

1.77 (0.12, 3.22)

Antihypertensive drugs n (%)

 No

1887

1.39 (0.80, 1.97)

 Yes

2857

1.32 (0.82, 1.81)

Current smoking (n %)

 No

3393

1.00 (0.55, 1.46)

 Yes

1351

2.14 (1.47, 2.82)

Current drinking (n %)

 No

3566

1.26 (0.81, 1.70)

 Yes

1178

1.52 (0.81, 2.24)

Labor intensity (n %)

 Low

2570

1.35 (0.81, 1.89)

 Middle

1095

1.48 (0.79, 2.16)

 High

1079

1.32 (0.50, 2.13)